Drug
Gen1106
Gen1106: highest development phase Phase 1, developed by Genmab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| GEN1106 NCT07416123 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow Gen1106 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.